Biomedical Institutions, Biomedical Funding, and Public Policy

1. Front Matter

   Pages i-xxiii

   PDF

2. Excellence and Creativity in Science

   • Rolf Luft, Hans Löw

   Pages 1-9

3. Basic Biomedical Research

   • H. Hugh Fudenberg

   Pages 11-39

4. Molecular Biology

   • Yuet Wai Kan

   Pages 41-52

5. Economic Impact of Recombinant DNA Technology

   • J. Leslie Glick

   Pages 53-77

6. Foundations and Their Contributions to the Shaping of Health Policy

   • Leighton E. Cluff, David E. Rogers

   Pages 79-92

7. Differing Approaches to Biomedical Research

   • Theodore Cooper, Susan Bennett

   Pages 93-113

8. World Endemic Disease

   • Graham V. Brown, G. J. V. Nossal

   Pages 115-149

9. The World Health Organization

   • H. C. Goodman, T. A. Lambo

   Pages 151-175

10. Histocompatibility Workshops

    • Jean Dausset, Felix T. Rapaport

    Pages 177-183

11. A Model for the Funding of Clinical Faculty in a Municipal Hospital

    • Chester W. Schmidt Jr., Philip D. Zieve, Burton C. D’Lugoff

    Pages 185-201

12. Economics of American Health Care

    • Victor R. Fuchs

    Pages 203-209

13. Back Matter

    Pages 211-212

    PDF

The world is on the threshold of a great new industrial revolution, a 1 scientific-industrial revolution. Recombinant DNA technology and hybridoma technology ("monoclonal antibodies") have already pro­ vided unique investment opportunities for venture capitalists. Hence published reports of biomedical research are no longer restricted to scientific journals, but now appear regularly not only in weekly news­ 2 magazines like Time and U. S. News & World Report,3 but also in the financial sections of The New York Times,4 The Wall Street Journal,S 6 8 Business Week, Fortune,7 and The Economist, as well as in such stock 9 market advisory publications as New Issues and Inc. (The Magazine for Growing Companies). 10 These publications now appear to be as impor­ tant to biomedical scientists in keeping abreast of new scientific devel­ opments in biotechnology as is Current Contents. (The costs of health­ cost provision and of fundamental biomedical research are now also being followed by such media. ) Conversely, Wall Street financial bro­ kers increasingly no longer confine their reading to economic journals but are also perusing Nature,ll Science,12 and Science N 13 for infor­ ews mation on both fiscal and scientific advances in these areas. It is obvious that the information explosion in biotechnology is crossing traditional boundaries (e. g. , ref. 14). This volume is the second of several that are intended to inform both the biomedical community and interested intelligent laymen of the political and economic implications of biomedical research.

• evolution
• health
• information
• media
• nature
• research
• technology
• time

• Medical University of South Carolina, Charleston, USA

  H. Hugh Fudenberg

Policies and ethics